PATENT CLAIM ANALYSIS

Application Number: 16285353
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides new immunological compositions and vaccines comprising selected  M. tuberculosis  antigens and antigenic peptides as well as nucleic acids encoding said antigens for use in the prevention, prophylaxis and treatment of mycobacterial infection, especially tuberculosis. In particular the invention provides recombinant BCG based vaccines in which one or more of the selected  M. tuberculosis  antigens are over expressed. The invention further provides isolated peptides for use in methods for diagnosing, characterizing, or classifying mycobacterial infections.

Claim (Index 1):
A method for immunizing a subject against infection caused by a mycobacterial species or for eliciting an immune response to a mycobacterial species in said subject, comprising the step of administering to said subject a vaccine composition or an immunological composition consisting essentially of:\n a first polypeptide having the amino acid sequence of SEQ ID NO: 1; a second polypeptide having the amino acid sequence of SEQ ID NO:2; and a third polypeptide having the amino acid sequence of SEQ ID NO:3.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.57407
- Patent Class: 424.0
- Transitional Phrase Type: half
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13510869', '10593384', '13510862', '13244126', '14413565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7589708460914366
- 35 USC 102 Novelty (BERT): 0.4965411502785977
- Combined Prediction Score: 0.7327278765101527
- Mean Citation Score: 251.708414
- Max Citation Score: 253.38556
- Similarity Product: 201.7118220376396

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test